Intervention

ipratropium bromide

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions6

Lead sponsors shown6

Clinical trials

6 shown

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPDNCT02296047 · 2014-12-01

Ipratropium Bromide in Peri-Operative COPDNCT01943552 · 2013-10-01

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in AthletesNCT01691079 · 2012-12-01

Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)NCT00807534 · 2008-10-01

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00911651 · 2008-06-01

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway HyperresponsivenessNCT00605410 · 2008-01-01

Common conditions

Asthma1 Bronchospasm, Exercise-Induced1 Chronic Obstructive Pulmonary Disease1 Chronic Obstructive Pulmonary Disease (COPD)1 COPD1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

Boehringer Ingelheim1 Laval University1 University Hospital, Antwerp1 University of California, San Francisco1 University of Saskatchewan1 Zhujiang Hospital1

Trial status mix

COMPLETED6

Phase mix

PHASE44

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.